NGS-Based RNA-Seq Market to surpass US$ 7,984.90 Mn in 2027 : Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies

The Insight Partners analysts forecast the global NGS-Based RNA-Seq market to grow at a CAGR of over 19.3% during the forecast period, according to their latest market research report.

The NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGs based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. The report would be of an interest to various stakeholders operating in the NGS based RNA seq market. These stakeholders include manufacturing companies, dealer companies, supplier companies, wholesalers, hospitals, research centers and others.

Request Sample Copy of this Report@: http://bit.ly/2T7zSDV

NGS-Based RNA-Seq Market includes the top key players such:Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc. and Eurofins Scientific.

The objective of the study is to describe, define, and forecast the NGS based RNA seq market by product & services, technology, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The global NGS based RNA seq market is expected to reach US$ 7,984.90 Mn in 2027 from 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.

NGS based RNA seq market is segmented by product & services, technology, application and end user. Global NGS based RNA seq market, based on product & services was segmented into sample preparation, sequencing services, sequencing platform & consumables and data analysis, storage & management. Global NGS based RNA seq market, based on technology was segmented into sequencing by synthesis, nanopore sequencing, ion semiconductor sequencing and single molecule real time sequencing. Global NGS based RNA seq market, based on application was classified as diagnostics, drug discovery, precision medicine and others. And on the basis of the end user the global NGS based RNA seq market was segmented as biotechnology & pharmaceutical companies, hospitals & clinics, research centers and academic & government institutes and others.

The NGS based RNA seq market report analyzes factors affecting NGS based RNA seq market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, , opportunities, and future trend. The report provides the analysis for the every segment in detail across all the regions such as North America, Europe, Asia Pacific, Middle East & Africa and South and Central America.

The market players offers products such as reagents and kits, instruments and consumables required for the sequencing. Among the companies profiled in the report Illumina Inc. and Thermo Fisher Scientific Inc. are the top two major players operating in the market.

Buy This Informative Research Report http://bit.ly/2T2qv8i

Objective of the Study:
1. Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global NGS-Based RNA-Seq Market
2. Highlights key business priorities in order to assist companies to realign their business strategies
3. The key findings and recommendations highlight crucial progressive industry trends in the NGS-Based RNA-Seq Market, thereby allowing players across the value chain to develop effective long term strategies
4. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
5. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
6. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
7. Examine the political, economic, social and technology impact of the five regions namely: North America, Europe, Asia Pacific, Middle East & Africa and South America.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.